0022

COM:NHWA-GROUP

江苏恩华药业股份有限公司

  • Stock

CNY

Last Close

26.09

25/11 07:04

Market Cap

22.50B

Beta: -

Volume Today

9.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
171.96M
-
202.57M
17.80%
242.82M
19.87%
283.79M
16.87%
329.27M
16.02%
386.16M
17.28%
377.99M
2.12%
389.67M
3.09%
519.10M
33.21%
660.34M
27.21%
672.49M
1.84%
average payables
319.72M
-
313.29M
2.01%
298.53M
4.71%
314.02M
5.19%
331.70M
5.63%
341.40M
2.93%
240.16M
29.65%
146.37M
39.05%
216.18M
47.70%
261.46M
20.94%
236.01M
9.73%
average receivables
518.53M
-
585.02M
12.82%
647.30M
10.65%
758.59M
17.19%
800.58M
5.54%
892.02M
11.42%
848.77M
4.85%
657.83M
22.50%
699.16M
6.28%
847.49M
21.22%
1.01B
19.70%
book value per share
0.85
-
1.06
24.51%
1.80
69.11%
2.08
15.47%
2.43
17.05%
2.93
20.53%
3.60
22.99%
4.07
13.06%
4.87
19.63%
5.55
13.99%
6.39
14.97%
capex per share
-0.11
-
-0.27
152.47%
-0.21
19.49%
-0.10
52.82%
-0.16
62.44%
-0.17
2.80%
-0.16
5.69%
-0.27
66.37%
-0.20
23.09%
-0.32
58.64%
-0.37
14.64%
capex to depreciation
-2.82
-
-5.98
111.83%
-4.37
26.96%
-1.99
54.37%
-2.74
37.31%
-1.56
43.14%
-1.82
16.83%
-2.77
52.54%
-1.53
44.99%
-2.20
44.48%
-2.14
3.12%
capex to operating cash flow
-0.53
-
-1.63
206.16%
-1.06
35.03%
-0.37
65.23%
-0.37
0.50%
-0.42
14.98%
-0.52
24.16%
-0.22
58.93%
-0.29
36.62%
-0.38
29.49%
-0.36
6.48%
capex to revenue
-0.05
-
-0.10
125.67%
-0.08
25.13%
-0.03
56.74%
-0.05
44.41%
-0.04
9.55%
-0.04
12.68%
-0.08
106.85%
-0.05
34.47%
-0.08
45.60%
-0.08
1.38%
cash per share
0.44
-
0.42
4.77%
0.74
77.78%
0.73
0.90%
0.76
3.96%
0.94
24.10%
1.88
99.38%
2.21
17.59%
2.64
19.33%
2.95
11.67%
3.47
17.62%
days of inventory on hand
51.85
-
51.99
0.27%
61.50
18.28%
66.57
8.24%
74.79
12.36%
88.55
18.40%
81.29
8.20%
192.63
136.96%
245.82
27.62%
256.22
4.23%
157.12
38.68%
days payables outstanding
88.29
-
73.21
17.08%
66.89
8.63%
74.79
11.81%
68.22
8.79%
76.10
11.55%
30.01
60.56%
73.34
144.38%
108.68
48.18%
91.47
15.83%
54.06
40.90%
days sales outstanding
90.27
-
90.04
0.26%
89.40
0.71%
101.55
13.60%
81.91
19.34%
96.73
18.10%
59.38
38.61%
69.56
17.14%
70.27
1.02%
79.59
13.25%
80.12
0.67%
debt to assets
0.18
-
0.19
8.60%
0.09
51.76%
0.09
5.25%
0.07
20.45%
0.08
11.94%
0.01
88.45%
0.01
11.52%
0.02
141.79%
0.01
26.48%
0.02
30.62%
debt to equity
0.33
-
0.36
7.08%
0.13
63.20%
0.13
4.32%
0.09
24.56%
0.11
13.35%
0.01
90.17%
0.01
12.18%
0.02
143.08%
0.02
26.79%
0.02
29.05%
dividend yield
0.00
-
0.00
0.72%
0.00
25.52%
0.00
7.98%
0.00
8.31%
0.01
117.19%
0.01
9.25%
0.01
2.97%
0.01
1.10%
0.01
26.03%
0.01
10.69%
earnings yield
0.02
-
0.02
19.92%
0.02
20.56%
0.02
29.15%
0.03
21.14%
0.06
109.57%
0.06
4.86%
0.05
20.56%
0.05
11.97%
0.04
28.18%
0.04
3.41%
enterprise value
9.08B
-
9.71B
6.97%
13.69B
40.98%
12.69B
7.36%
13.31B
4.90%
8.14B
38.80%
9.91B
21.63%
14.80B
49.42%
14.31B
3.34%
23.41B
63.63%
25.67B
9.66%
enterprise value over ebitda
33.45
-
28.63
14.43%
35.63
24.46%
28.48
20.08%
24.82
12.84%
10.72
56.80%
10.98
2.45%
15.24
38.79%
13.02
14.61%
20.13
54.65%
20.62
2.45%
ev to operating cash flow
46.73
-
60.62
29.73%
67.05
10.61%
45.78
31.73%
29.42
35.73%
20.13
31.57%
32.37
60.81%
11.86
63.38%
20.41
72.11%
27.19
33.24%
24.44
10.13%
ev to sales
4.06
-
3.88
4.37%
4.95
27.46%
4.20
15.07%
3.92
6.72%
2.11
46.17%
2.39
13.09%
4.40
84.45%
3.64
17.44%
5.45
49.82%
5.16
5.23%
free cash flow per share
0.09
-
-0.10
211.77%
-0.01
88.11%
0.17
1,511.00%
0.28
63.74%
0.23
18.36%
0.14
37.44%
0.97
567.75%
0.49
49.35%
0.53
7.47%
0.67
27.46%
free cash flow yield
0.01
-
-0.01
205.80%
-0.00
91.60%
0.01
1,620.06%
0.02
55.65%
0.03
28.69%
0.01
53.10%
0.06
386.28%
0.03
48.32%
0.02
31.49%
0.02
13.99%
graham net net
0.21
-
0.12
45.14%
0.66
467.61%
0.66
0.05%
0.67
2.10%
0.84
25.11%
1.96
133.17%
2.27
15.42%
2.72
19.87%
3.11
14.50%
3.73
20.07%
graham number
1.86
-
2.33
25.60%
3.22
37.93%
3.79
17.66%
4.62
22.13%
5.85
26.59%
7.31
24.94%
8.12
11.06%
9.31
14.57%
10.55
13.32%
12.16
15.30%
income quality
1.13
-
0.72
35.72%
0.80
10.47%
0.92
14.82%
1.21
31.22%
0.78
35.36%
0.47
40.24%
1.72
268.70%
0.88
48.83%
0.98
11.32%
1.01
3.59%
intangibles to total assets
0.04
-
0.04
2.46%
0.03
25.35%
0.03
18.18%
0.02
22.98%
0.03
36.24%
0.03
8.20%
0.03
1.54%
0.03
14.56%
0.03
17.42%
0.04
9.17%
interest coverage
11.95
-
13.34
11.67%
17.22
29.10%
30.27
75.73%
50.27
66.08%
44.42
11.63%
48.21
8.52%
538.73
1,017.51%
183.02
66.03%
202.82
10.82%
256.90
26.66%
interest debt per share
0.30
-
0.40
32.24%
0.25
36.63%
0.27
7.55%
0.24
12.12%
0.33
37.28%
0.05
83.57%
0.04
27.08%
0.11
191.93%
0.10
15.94%
0.14
45.13%
inventory turnover
7.04
-
7.02
0.27%
5.94
15.46%
5.48
7.62%
4.88
11.00%
4.12
15.54%
4.49
8.93%
1.89
57.80%
1.48
21.64%
1.42
4.06%
2.32
63.08%
invested capital
0.33
-
0.36
7.08%
0.13
63.20%
0.13
4.32%
0.09
24.56%
0.11
13.35%
0.01
90.17%
0.01
12.18%
0.02
143.08%
0.02
26.79%
0.02
29.05%
market cap
9.23B
-
9.75B
5.63%
14.20B
45.67%
13.18B
7.17%
13.87B
5.17%
8.80B
36.54%
11.69B
32.84%
16.17B
38.31%
15.80B
2.24%
24.85B
57.24%
27.66B
11.30%
net current asset value
422.34M
-
375.69M
11.05%
970.38M
158.29%
1.17B
20.20%
1.42B
21.54%
1.84B
29.56%
2.41B
31.03%
2.68B
11.21%
3.25B
21.41%
3.75B
15.50%
4.39B
16.97%
net debt to ebitda
-0.55
-
-0.10
81.08%
-1.32
1,173.17%
-1.11
15.42%
-1.04
6.73%
-0.86
17.16%
-1.98
129.47%
-1.41
28.92%
-1.36
3.08%
-1.24
9.11%
-1.60
28.93%
net income per share
0.18
-
0.23
26.69%
0.26
12.50%
0.31
19.88%
0.39
27.44%
0.52
32.96%
0.66
26.92%
0.72
9.09%
0.79
9.72%
0.89
12.66%
1.03
15.63%
operating cash flow per share
0.20
-
0.16
17.53%
0.20
23.93%
0.27
35.68%
0.45
63.26%
0.40
10.59%
0.30
24.04%
1.23
305.08%
0.69
43.70%
0.85
22.52%
1.04
22.58%
payables turnover
4.13
-
4.99
20.60%
5.46
9.44%
4.88
10.56%
5.35
9.64%
4.80
10.36%
12.16
153.57%
4.98
59.08%
3.36
32.51%
3.99
18.81%
6.75
69.22%
receivables turnover
4.04
-
4.05
0.26%
4.08
0.72%
3.59
11.97%
4.46
23.98%
3.77
15.32%
6.15
62.89%
5.25
14.63%
5.19
1.01%
4.59
11.70%
4.56
0.66%
research and ddevelopement to revenue
0.02
-
0.02
3.99%
0.02
22.46%
0.03
35.31%
0.04
35.85%
0.05
2.14%
0.07
60.61%
0.09
22.18%
0.11
18.25%
0.10
1.97%
return on tangible assets
0.12
-
0.12
3.31%
0.10
13.77%
0.11
2.19%
0.12
14.09%
0.13
9.76%
0.16
20.96%
0.16
2.74%
0.14
8.42%
0.14
0.21%
0.15
2.14%
revenue per share
2.28
-
2.55
11.88%
2.74
7.54%
2.99
9.07%
3.36
12.48%
3.82
13.66%
4.13
8.00%
3.32
19.57%
3.90
17.37%
4.25
8.96%
4.94
16.24%
roe
0.21
-
0.21
1.75%
0.14
33.47%
0.15
3.82%
0.16
8.87%
0.18
10.32%
0.18
3.20%
0.18
3.51%
0.16
8.28%
0.16
1.16%
0.16
0.57%
roic
0.15
-
0.16
1.77%
0.12
21.88%
0.12
1.14%
0.14
13.98%
0.16
13.59%
0.18
13.48%
0.18
2.52%
0.16
9.69%
0.16
2.41%
0.14
7.67%
sales general and administrative to revenue
0.05
-
0.02
60.77%
0.01
35.19%
0.01
1.00%
0.01
6.62%
0.01
8.66%
0.01
19.11%
0.01
4.82%
0.01
13.17%
0.01
6.98%
0.01
0.87%
shareholders equity per share
0.85
-
1.06
24.51%
1.80
69.11%
2.08
15.47%
2.43
17.05%
2.93
20.53%
3.60
22.99%
4.07
13.06%
4.87
19.63%
5.55
13.99%
6.39
14.97%
stock based compensation to revenue
-0.11
-
tangible asset value
770.54M
-
976.45M
26.72%
1.75B
78.76%
2.05B
17.21%
2.39B
17.05%
2.84B
18.79%
3.50B
22.99%
3.98B
13.86%
4.74B
18.89%
5.36B
13.19%
6.19B
15.42%
tangible book value per share
0.79
-
1.00
26.74%
1.73
73.81%
2.03
17.20%
2.37
17.07%
2.82
18.76%
3.48
23.51%
3.94
13.05%
4.69
19.18%
5.30
12.92%
6.14
15.96%
working capital
450.13M
-
410.04M
8.91%
1.00B
145.09%
1.20B
19.55%
1.52B
26.16%
1.93B
27.18%
2.49B
29.03%
2.74B
10.34%
3.36B
22.47%
3.86B
14.73%
4.44B
15.15%

All numbers in CNY (except ratios and percentages)